CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Global Blood Therapeutics, Inc.

For profitContributed to NMEWebsite ↗

Also known as: GBT | Global Blood Therapeutics | Global Blood Therapeutics, Inc. | GLOBAL BLOOD THERAPS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2014

First marketed drug

Nov 25, 2019

Last known activity

Jan 3, 2023

Acquired by Pfizer on Aug 8, 2022

Timeline

2010s

  1. Jun 1, 2012

    Global Blood Therapeutics, Inc.— Founded

  2. Nov 25, 2019

    voxelotor— Marketing Organization

2020s

  1. Aug 8, 2022

    Pfizer— Acquired By

Drugs by trial phase (3 distinct, 29 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (47)

Details

Founded
San Francisco, CA, US Jun 1, 2012
Last known activity
Jan 3, 2023

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Breakthrough therapy
  • Accelerated approval